Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy

Introduction The aim of this study was to determine prognostic factors for the risk of new vascular events during the first 6 months after acute myocardial infarction (AMI) or atherothrombotic stroke (AS). We were interested in the prognostic role of endothelial progenitor cells (EPC) and circulating endothelial cells (CEC) Methods Between February 2009 and July 2012, 100 AMI and 50 AS patients were consecutively studied in three Spanish centres. Patients with previously documented coronary artery disease or ischemic strokes were excluded. Samples were collected within 24h of onset of symptoms. EPC and CEC were studied using flow cytometry and categorized by quartiles. Patients were followed for up to 6 months. NVE was defined as new acute coronary syndrome, transient ischemic attack (TIA), stroke, or any hospitalization or death from cardiovascular causes. The variables included in the analysis included: vascular risk factors, carotid intima-media thickness (IMT), atherosclerotic burden and basal EPC and CEC count. Multivariate survival analysis was performed using Cox regression analysis. Results During follow-up, 19 patients (12.66%) had a new vascular event (5 strokes; 3 TIAs; 4 AMI; 6 hospitalizations; 1 death). Vascular events were associated with age (P = 0.039), carotid IMT≥0.9 (P = 0.044), and EPC count (P = 0.041) in the univariate analysis. Multivariate Cox regression analysis showed an independent association with EPC in the lowest quartile (HR: 10.33, 95%CI (1.22–87.34), P = 0.032] and IMT≥0.9 [HR: 4.12, 95%CI (1.21–13.95), P = 0.023]. Conclusions Basal EPC and IMT≥0.9 can predict future vascular events in patients with AMI and AS, but CEC count does not affect cardiovascular risk.

[1]  A. Oliveras,et al.  Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke. , 2015, Journal of molecular and cellular cardiology.

[2]  J. Roquer,et al.  Relevance of stroke subtype in vascular risk prediction , 2013, Neurology.

[3]  Cheree James,et al.  Autonomic markers of emotional processing: skin sympathetic nerve activity in humans during exposure to emotionally charged images , 2012, Front. Physio..

[4]  Giel Nijpels,et al.  Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. , 2012, JAMA.

[5]  Emmanuel Touzé,et al.  Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. , 2012, Stroke.

[6]  Lu Gao,et al.  Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data , 2012, The Lancet.

[7]  O. Resta,et al.  Is there a correlation between OSAS duration/severity and carotid intima-media thickness? , 2012, Respiratory medicine.

[8]  S. Stringer,et al.  Endothelial Progenitor Cells Enter the Aging Arena , 2012, Front. Physio..

[9]  J. Serena,et al.  Value of Carotid Intima-Media Thickness and Significant Carotid Stenosis as Markers of Stroke Recurrence , 2011, Stroke.

[10]  J. Montaner,et al.  Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. , 2010, Microvascular research.

[11]  D. Fliser,et al.  Endothelial Progenitor Cells and Cardiovascular Events in Patients with Chronic Kidney Disease – a Prospective Follow-Up Study , 2010, PloS one.

[12]  A. Avogaro,et al.  Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. , 2009, Atherosclerosis.

[13]  K. Chayama,et al.  Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. , 2008, American journal of hypertension.

[14]  Cheng-Hsien Lu,et al.  Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke , 2008, Stroke.

[15]  R. Elosua,et al.  Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[16]  A. Avogaro,et al.  Endothelial progenitor cells in the natural history of atherosclerosis. , 2007, Atherosclerosis.

[17]  M. Gomis,et al.  Atherosclerotic burden and early mortality in acute ischemic stroke. , 2007, Archives of neurology.

[18]  Deepak L. Bhatt,et al.  One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.

[19]  G. Lip,et al.  Circulating endothelial cells in cardiovascular disease. , 2006, Journal of the American College of Cardiology.

[20]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[21]  K. Furie,et al.  An evidence‐based causative classification system for acute ischemic stroke , 2005, Annals of neurology.

[22]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[23]  M. Gnecchi,et al.  Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. , 2005, Hypertension.

[24]  G. Lip,et al.  Circulating endothelial cells in acute ischaemic stroke , 2005, Thrombosis and Haemostasis.

[25]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[26]  N. Abraham,et al.  Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c , 2005, Diabetologia.

[27]  G. Lip,et al.  Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. , 2005, Blood.

[28]  E. Vicaut,et al.  Mannheim Intima-Media Thickness Consensus , 2004, Cerebrovascular Diseases.

[29]  G. Lip,et al.  Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. , 2004, European heart journal.

[30]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[31]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[32]  D. Hess,et al.  Bone Marrow as a Source of Endothelial Cells and NeuN-Expressing Cells After Stroke , 2002, Stroke.

[33]  S. Rafii,et al.  Contribution of marrow-derived progenitors to vascular and cardiac regeneration. , 2002, Seminars in cell & developmental biology.

[34]  S. Fichtlscherer,et al.  Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.

[35]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[36]  Arno W. Hoes,et al.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.

[37]  J. Arenillas,et al.  Intracranial atherosclerosis: current concepts. , 2011, Stroke.

[38]  N. Abraham,et al.  Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. , 2005, Diabetologia.